Our finding indicated that the expression of ZYX and p53 genes in tumor tissues of estrogen receptor‐positive patients had significant difference from estrogen receptor‐negative patients (p < 0.001, p < 0.001, respectively) (Figure 1C). The gene discussed is TP53; the disease is neoplasm.